However, as PCa continues to be studied, routine indicators such as PSA detection, Gleason score and pathological stage are difficult to adapt to the needs of individual differences and complex diseases, and fail to provide accurate prediction of BCR risk in PCa (20). This evidence concerns the gene KLK3 and posterior cortical atrophy.